The Psoralen plus Ultraviolet-A (PUVA) cohort study has been a tremendous success in
determining how a novel treatment (ie, PUVA) affects the long-term risk of keratinocyte …

Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis is a chronic inflammatory skin disease that is characterized by T-cell mediated
immune response, and has been known to increase the risk of developing hypertension …

Psoriasis has been traditionally viewed as an inflammatory skin disorder of unknown origin.
Recent advances in the immunopathogenesis and genetics of psoriasis have broadened …

Background Coexisting long-term conditions (LTCs) in psoriasis and their potential causal
associations with the disease are not well established. Objectives To determine distinct …

Introduction. Several studies reported an increased cardiovascular (CV) morbidity and
mortality in patients with psoriatic arthritis (PsA). We performed a meta-analysis on the …

Background Recent cross‐sectional studies reported a higher prevalence of diabetes and
other risk factors for cardiovascular disease in patients with psoriasis than in the general …

Psoriasis, a systemic inflammatory disease, is associated with enhanced atherosclerosis
and risk of cardiovascular (CV) disease, which may account for higher morbidity and …

Psoriasis is a chronic inflammatory skin disease that is associated with an increased
cardiovascular risk profile. The systemic inflammation present in psoriasis, various systemic …

The association between psoriasis and risk of atherosclerotic cardiovascular disease has
not been thoroughly evaluated in a large longitudinal cohort of an Asian population. We …